首页> 美国卫生研究院文献>Neurologia medico-chirurgica >Endovascular Treatment for Ruptured Vertebral Artery Dissecting Aneurysms: Results from Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2
【2h】

Endovascular Treatment for Ruptured Vertebral Artery Dissecting Aneurysms: Results from Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2

机译:破裂性椎动脉夹层动脉瘤的血管内治疗:日本神经内血管治疗注册中心(JR-NET)1和2的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In treating ruptured vertebral artery dissecting aneurysms (VADAs), neuroendovascular therapy (NET) represented by coil obliteration is considered to be a reliable intervention. However, there has been no multi-center based study in this setting so far. In this article, results of NET for ruptured VADA obtained from Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2 were assessed to elucidate the factors associated with favorable outcome. A total of 213 in JR-NET1 and 381 patients in JR-NET2 with ruptured VADA were included, and they were separately analyzed because several important datasets such as vasospasm and site of dissecting aneurysms in relation to the posterior inferior cerebellar artery (PICA) were collected only in JR-NET1. The ratio of poor World Federation of Neurosurgical Societies (WFNS) grade (4 and 5) was 48.8% and 53.9%, and the ratio of favorable outcome (modified Rankin scale, mRS 0 to 2) at 30 days after onset was 61.1 % and 49.1% in JR-NET1 and 2, respectively. In both studies, poor WFNS grade and procedural complication were independently correlated as negative factors for favorable outcome. In JR-NET1, PICA-involved lesion was also designated as a negative factor while elderly age and absence of postprocedural antithrombotic therapy was detected as other negative factors in JR-NET2. The ratios of favorable outcome in poor grade patients were 25.4% in JR-NET1 and 31.3% in JR-NET2, which seemed compatible with the previous studies. These results may provide a baseline data for the NET in this disease and could be useful for validating the benefits of novel devices.
机译:在治疗破裂性椎动脉夹层动脉瘤(VADAs)时,以线圈闭塞为代表的神经内血管治疗(NET)被认为是一种可靠的干预措施。但是,到目前为止,在这种情况下还没有基于多中心的研究。在本文中,评估了从日本神经内膜血管疗法注册处(JR-NET)1和2获得的VADA破裂的NET结果,以阐明与预后良好相关的因素。总共纳入了213例VADA破裂的JR-NET1患者和381例JR-NET2患者,并对其进行了单独分析,因为包括几个重要的数据集,如血管痉挛和与小脑后下动脉相关的夹层动脉瘤部位仅在JR-NET1中收集。世界神经外科学会联合会(WFNS)等级为(4和5)的贫困率分别为48.8%和53.9%,发病后30天的良好结局(改良的Rankin量表,mRS 0至2)为61.1%,在JR-NET1和2中分别为49.1%。在两项研究中,不良的WFNS评分和手术并发症均独立关联为不良预后的负面因素。在JR-NET1中,PICA累及的病变也被指定为阴性因素,而在JR-NET2中,老年人和无术后抗栓治疗被检测为其他阴性因素。不良品级患者的良好转归比率在JR-NET1中为25.4%,在JR-NET2中为31.3%,这似乎与以前的研究相吻合。这些结果可能为该疾病的NET提供基线数据,并可能有助于验证新型设备的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号